Skip to content

Identification of the Optimal Treatment Strategy for Complex Appendicitis in the Pediatric Population

The Identification of the Optimal Treatment Strategy for Complex Appendicitis in the Pediatric Population

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04755179
Acronym
CAPP
Enrollment
1308
Registered
2021-02-16
Start date
2019-08-12
Completion date
2024-07-03
Last updated
2024-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Appendicitis, Appendix Mass, Appendicitis Perforated

Keywords

Complex appendicitis, Children, Treatment

Brief summary

Aim of this study is to evaluate the effect of different treatment strategies on overall complications, health related-Quality of Life (hr-QOL) and costs among two subtypes of complex appendicitis in children (\<18 years old). Main research questions: What is the difference in overall complications at three months between: Subgroup 1 (complex appendicitis without abscess/mass formation): Laparoscopic (LA) and open appendectomy (OA) Subgroup 2: (complex appendicitis with abscess/mass formation): Non-operative treatment (NOT) and direct appendectomy

Detailed description

Up till now initiated research projects worldwide mainly focus on simple appendicitis (questioning the necessity of an appendectomy). However, complex appendicitis is associated with significant morbidity (up to 30%), prolonged hospital stay and high costs. Identification of the optimal treatment strategy for children with complex appendicitis is therefore essential. Heterogeneity in the treatment of complex appendicitis still exists in daily practice and reflects the lack of high-quality data and emphasizes the need for well-designed studies. Complex appendicitis can be divided into two subtypes: 1. Complex appendicitis without mass/abscess. (subgroup 1) Although (inter)national guidelines agree that appendectomy should be usual care, the optimal approach (open or laparoscopy) is unclear. Laparoscopic appendectomy (LA) is increasingly applied both in adults (80%) and children (60%). Benefits reported for LA in children are, but not limited to, less superficial site infection (SSI), reduced length of hospital stay and significant less postoperative bowel obstruction compared with open appendectomy (OA). Reluctance for usage of LA in this specific subgroup, however, remains due to the potential higher incidence of post-appendectomy abscess formation (PAA) reported. However, the quality of studies on this topic is low and there is considerable inconsistency in results. 2. Complex appendicitis with mass/abscess. (subgroup 2) The recommendation made in our national guideline (to perform direct appendectomy in this subgroup) is not in line with the available literature. A recent Cochrane review on this topic could only include two trials and stated that no firm conclusions could be drawn. An older systematic review, including 7 studies in children, concluded that non-operative treatment (NOT) led to fewer complications, specifically SSI and PAA, when compared to direct appendectomy. Still the recommendation from our national guideline is to perform a direct appendectomy based upon good experiences in the pediatric academic centers. In order to investigate the optimal treatment for children with complex appendicitis we will perform a nationwide, multi-center, comparative, prospective cohort study. For the purpose of this study, treatment strategies will be standardized among the participating hospitals in order to reduce heterogeneity. Prospectively derived, high quality data will be sufficient to answer the research questions regarding the optimal treatment strategy for each subtype of complex appendicitis in the pediatric population. As it is a non-randomized prospective cohort study, propensity score matching technique will be performed in order to estimate the effect of the treatments adjusted for potential confounders.

Interventions

PROCEDURELaparoscopic appendectomy

Laparoscopic appendectomy is performed according to daily practice but with the following standardized key points: 1. Conventional laparoscopy (three-trocar technique) 2. In case of purulent fluid: Suction and no peritoneal lavage procedure 3. Skelletizing of the mesoappendix (coagulation/clips according to routine practice locally) 4. Appendiceal stump closure: with two endoloops and dissected between the endoloops. In case of involvement of the appendiceal base, the use of endostapler is recommended. 5. Withdrawal of appendix: principle of abdominal wall protection is followed (trocar technique / endobag) 6. No drain placement, no nasogastric tube, and no urinary catheter routinely, only on indication. 7. Closure of wounds as appropriate

Open appendectomy will be performed according to the following standardized key points: 1. Gridiron incision at the right lower quadrant. (McBurney's point) 2. After obtaining access to the abdominal cavity the principle of abdominal wall protection will be followed. 3. The appendiceal stump will be closed by ligation, not a purse string suture. 4. Closure of wounds as appropriate

Non-operative treatment consisting of administration of intravenous antibiotics with or without drainage procedures (in case of an abscess), reserving an appendectomy for those not responding or with recurrent disease. One of the two antibiotic regiments: 1. Combination A: 1. Amoxicillin/clavulanic acid 25/2.5mg/kg 6 hourly (total 100/10 mg/kg daily. Maximum 6000/600mg a day) for children \<40 kg OR Amoxicillin/clavulanic acid 1000/200mg/kg 8 hourly (total 3000/6000 mg/kg daily) for children \> 40 kg 2. Gentamicin 7mg/kg once daily 2. Combination B: 1. Cefuroxim 25 mg/kg 6 hourly (total 100 mg/kg/day. Maximum 6gram/day) 2. Metronidazole 10mg/kg 8hourly (total 30 mg/kg/day. Maximum 4000 mg/day) In case of peri-appendicular abscess the decision can be made to perform a drainage procedure either percutaneously or surgical.

PROCEDUREDirect appendectomy

laparoscopic or open appendectomy as described

Sponsors

ZonMw: The Netherlands Organisation for Health Research and Development
CollaboratorOTHER
Amsterdam UMC, location VUmc
CollaboratorOTHER
Ramon Gorter
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
0 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

Eligible for inclusion are all children \<18 years old that need to undergo treatment for the suspicion of complex appendicitis. Suspicion of complex appendicitis is based upon the following predefined criteria: 4 or more points on our scoring system developed to predict complex appendicitis. The diagnostic accuracy of this scoring system is 91% (Range: 84-98%). This scoring system consists of five variables (clinical, biochemical and radiological,each awarded points). In case the total score is 4 or more points, the patient is likely to have complex appendicitis. Variables included in the scoring system are: * Diffuse abdominal guarding (3 points) * CRP level more than 38 mg/L (2 points) * Signs on ultrasound / imaging indicative for complex appendicitis (2 points) * More than one day abdominal pain (2 points) * Temperature more than 37.5 degrees Celsius (1 point) Or High index of suspicion of complex appendicitis by the treating physician. If this is the case, the treating physician will make pre-treatment note upon what clinical, biochemical or radiological variable the high index of suspicion is based.

Exclusion criteria

* Adult patients (=18 years old) * Children with a suspicion of simple appendicitis (based upon the previous mentioned scoring system and radiological features)

Design outcomes

Primary

MeasureTime frameDescription
Overall complications3 monthsThe proportion of patients experiencing any complication within 3 months after inclusion

Secondary

MeasureTime frameDescription
Total number of extra visits30 days, 3 monthsTotal number of extra visits to the outpatient clinic, general pratctitioner's office or emergency department
Length of hospital stay3 monthsTotal length of hospital stay during follow-up due to trategy related treatment or complications
Postappendectomy abscess3 monthsProportion patients with a postappendectomy abscess
Superficial Site Infection3 monthsProportion of patients with a superficial site infection
Secondary bowel obstruction3 monthsProportion of patients with a secondary/prolonged bowel obstruction
Days absent from school, social or sports events30 days, 3 monthsNumber of days absent from school, social or sports events
Number of days absent from work30 days, 3 monthsNumber of days that parents are absent from work
Pain medication utilization30 days, 3 monthsPain medication utilization during admission
Need for appendectomy3 monthsProportion of patients not having to undergo appendectomy within 3 months after start of non-operative treatment
Level of painat inclusion/baseline (=day 0), 3 days, 5 days, 30 days, 3 monthsLevel of pain measured according to the Visual Analogue Scale (0-10 points, higher scores indicating worse outcomes)
Early failure of non-operative treatment3 monthsProportion of patients experiencing early failure of initial non-operative treatment
Quality of Life questionnaire (EQ-5d-Youth/EQ-5d-Proxy)at inclusion/baseline (=day 0), 30 days, 3 monthsQoL measured by the validated EQ-5d-Youth / EQ-5d-Proxy questionnaire (0-1 point, higher scores indicating better outcome)
Quality of Life questionnaire (PedsQL 4.0)at inclusion/baseline (=day 0), 30 days, 3 monthsQoL measured by the validated Pediatric Quality of Life Inventory 4.0 (PedsQL 4.0) (0-100 points, higher scores indicating better outcome) Labor Questionnaire (HLQ), Medical Consumption Questionnaire (iMCQ) and Productivity Consumption Questionnaire (iPCQ) and gathered actual health care cost
Medical costs (iMCQ)at inclusion/baseline (=day 0), 30 days, 3 monthsMedical costs measured by the iMedical Consumption Questionnaire
Non-medical / indirect costs (iPCQ)at inclusion/baseline (=day 0), 30 days, 3 monthsNon-medical / indirect costs measured by the iProductivity Cost Questionnaire
Quality adjusted life months (QALM's)3 monthsQuality adjusted life months calculated using outcomes 14 -17
Patient satisfaction questionnaire (PSQ-18)3 monthsPatient satisfaction measured by the Patient Satisfaction Questionnaire (PSQ) (0-100, higher scores indicating better outcome)
Patient satisfaction questionnaire (Net promotor score)3 monthsPatient satisfaction measured by the NET PROMOTOR SCORE (0-10, higher scores indicating better outcome)
Recurrent appendicitis3 monthsProportion of patients experiencing recurrent appendicitis within 3 months after inclusion

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 13, 2026